Parameters of Reserpine Analogs That Induce MSH2/MSH6-Dependent Cytotoxic Response

Aksana Vasilyeva1, Jill E Clodfelter, Michael J Gorczynski

  • 1Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA.

Journal of Nucleic Acids
|October 12, 2010
PubMed

Insights

Researchers identified key molecular features of reserpine analogs that induce MSH2/MSH6-dependent cell death. This discovery helps in developing chemotherapy drugs that bypass resistance in mismatch repair-deficient cells.

Area of Science:

  • Molecular biology
  • Medicinal chemistry
  • Cancer research

Background:

  • Mismatch repair (MMR) proteins influence chemotherapy efficacy.
  • A novel "death conformation" of MutS homologous proteins, distinct from their repair function, can induce DNA-independent cell death.
  • Reserpine can trigger this death conformation.

Purpose of the Study:

  • To identify structural and chemical parameters of reserpine-like molecules required for MSH2/MSH6-dependent cytotoxicity.
  • To understand the interaction of reserpine analogs with MSH2/MSH6 proteins.

Main Methods:

  • Multidisciplinary approach combining structural modeling, chemical synthesis, and cell biology.
  • Analysis of reserpine analogs and modifications.
  • Investigation of MSH2/MSH6 protein interactions.

Main Results:

  • Specific molecular features, including methoxy groups, molecular size, and binding orientation, are critical for inducing MSH2/MSH6-dependent cytotoxicity.
  • The reserpine analog, rescinnamine, demonstrated enhanced MSH2-dependent cytotoxicity.
  • Identified key parameters for reserpine-analogous molecule interaction with MSH2/MSH6.

Conclusions:

  • The study elucidates the molecular basis for MSH2/MSH6-dependent cytotoxicity induced by reserpine analogs.
  • Findings facilitate the development of novel chemotherapeutic agents that require functional MMR proteins.
  • This approach may help overcome resistance in MMR-deficient cancers.

Related Concept Videos

Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...